Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05394675 · ClinicalTrials.gov registry record · Phase 1
A Study of DS-9606a in Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Daiichi Sankyo.
- Terminated
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT05394675 is a Phase 1 study that was terminated before completion, run by Daiichi Sankyo. The registered enrollment target is 88 participants.
The verdict
NCT05394675, a Phase 1 study, was terminated before completion, sponsored by Daiichi Sankyo.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study will assess the safety and tolerability of DS-9606a in patients with advanced solid tumors.
Interventions
- DRUG DS-9606a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2026-02-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05394675
The ClinicalTrials.gov registry entry for NCT05394675 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DS-9606a is the first listed.
NCT05394675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05394675 about?
NCT05394675 is a clinical study titled "A Study of DS-9606a in Patients With Advanced Solid Tumors". This study will assess the safety and tolerability of DS-9606a in patients with advanced solid tumors.
What is the current status of trial NCT05394675?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2022-05-31. Estimated completion is 2026-02-06.
What interventions are being tested in trial NCT05394675?
The interventions under investigation include: DS-9606a (DRUG).
Who is sponsoring clinical trial NCT05394675?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.